Results 131 to 140 of about 33,657 (222)

Dengue: defining protective versus pathologic immunity

open access: yes, 2008
Dengue is an expanding public health problem, and an effective vaccine remains elusive. This review discusses how the significant influence of sequential infection with different dengue virus serotypes on the severity of disease can be viewed in terms of
Rothman, Alan L.
core   +1 more source

Barriers to dengue vaccine uptake in international travelers: a mixed-methods study

open access: yesExpert Review of Vaccines
Background Dengue poses a growing threat to international travelers, yet vaccine uptake remains limited due to inconsistent guidelines and psychological barriers. This study provides barriers and determinants of hesitancy, which may guide strategies once
Rachata Charoenwisedsil   +6 more
doaj   +1 more source

Feasibility and willingness to pay for dengue vaccine in the threat of dengue fever outbreaks in Vietnam

open access: yes, 2018
Long Hoang Nguyen,1 Bach Xuan Tran,2–4 Cuong Duy Do,5 Chi Linh Hoang,6 Thao Phuong Nguyen,2 Trang Thi Dang,2 Giang Thu Vu,7 Tung Thanh Tran,7 Carl A Latkin,3 Cyrus S Ho,8 Roger CM Ho9 1Department of Public Health Sciences, Karolinska Institutet ...
Ho CS   +10 more
core  

Example structures of dengue models.

open access: yes, 2013
The disease state space of five alternative dengue model structures incorporating immune enhancement and short-term cross protection are shown. The disease states are: S susceptible, E exposed but not yet infectious, Ii infectious with serotype i, Iij ...
WHO-VMI Dengue Vaccine Modeling Group (614252)
core   +1 more source

The dengue vaccine dilemma [PDF]

open access: yesThe Lancet Infectious Diseases, 2018
openaire   +2 more sources

Safety of Dengue Vaccine? [PDF]

open access: yesClin Infect Dis, 2023
Biswal S, Patel SS, Rauscher M.
europepmc   +2 more sources

Dengue vaccines

open access: yes, 2013
Scott B. Halstead, Stephen J. Thomas
openaire   +1 more source

The need for balanced dengue vaccine protection: Insights from Thai surveillance data on four serotypes. [PDF]

open access: yesPLoS Negl Trop Dis
Khosavanna RR   +7 more
europepmc   +1 more source

Efficacy of Multivalent Dengue Vaccine Candidates Predicted In Silico. [PDF]

open access: yesVaccines (Basel)
Hyeon S   +6 more
europepmc   +1 more source

Author Correction: The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccine. [PDF]

open access: yesNPJ Vaccines
Escudero I   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy